by WorldTribune Staff, December 15, 2022
Data submitted by Moderna to the Food and Drug Administration (FDA) on its mRNA Covid-19 vaccine indicates a “statistically significant” number of rats were born with skeletal deformations after their mothers were injected with the vaccine, a government watchdog group reported.
Judicial Watch obtained the records through a September 2021 Freedom of Information Act (FOIA) lawsuit filed after the FDA, the CDC and the National Institute for Allergy and Infectious Disease (NIAID) failed to respond to a June 2021, FOIA request for biodistribution studies and related data for the Pfizer, Moderna and Johnson & Johnson Covid vaccines.
“These previously hidden records about the Covid-19 vaccine safety and efficacy studies raise a number of disturbing questions,” said Judicial Watch President Tom Fitton. “The fact that it has taken a federal lawsuit to get access to this material is yet another scandal.”
The records obtained by Judicial Watch include a “Nonclinical Overview” prepared by Moderna and submitted to the FDA for approval of its vaccine revealing that a number of rats were born with skeletal deformations, known as “wavy ribs” and “rib nodules,” to mothers injected with the mRNA vaccine. The study dismissed the anomalies as “not considered adverse:”
mRNA-1273-related variations in skeletal examination included statistically significant increases in the number of F1 rats with 1 or more wavy ribs and 1 or more rib nodules. Wavy ribs appeared in 6 fetuses and 4 litters with a fetal prevalence of 4.03% and a litter prevalence of 18.2%. Rib nodules appeared in 5 of those 6 fetuses. Skeletal variations are structural changes that do not impact development or function of a developing embryo, are considered reversible, and often correlate with maternal toxicity and/or lack of other indicators of developmental toxicity (Carney and Kimmel 2007). Maternal toxicity in the form of clinical observations was observed for 5 days following the last dose (GD 13), correlating with the most sensitive period for rib development in rats (GDs 14 to 17). Furthermore, there were no other indicators of mRNA-1273-related developmental toxicity observed, including delayed ossification; therefore, these common skeletal variations were not considered adverse.
In one appendix to the study, titled “Summary Mean (±SE) mRNA-1647 Pharmacokinetic Parameters in Sprague-Dawley Rat in Plasma and Tissues Following 100μg Intramuscular Injection Administration of mRNA-1647 on Day 1,” reveals that, in addition to distributing to the muscle site, lymph nodes and spleen, the mRNA particles also distributed to the bone marrow, brain, eyes, heart, liver, lungs, stomach and testes.
A separate study indicates that the mRNA-1647 particles injected into rats were “observed in muscle (i.e. site of injection), followed by proximal (popliteal) lymph nodes, axillary lymph nodes and spleen, suggesting the mRNA-1647 distribution to the circulation by lymph flow.” (The mRNA was delivered via “lipid nanoparticle dispersion.”)